NIH-funded research R01 grant

NMES approach to protect and restore thigh muscles after ACL injury

Official title: Mechanistic Assessment of NMES to Rescue Localized Neuromuscular Disruption after ACL Injury

Funded at University of Kentucky · NIH-11382049 · Data updated 2026-11-12

A researcher team at the University of Kentucky is testing how nerve-stimulating electrical therapy might prevent and reverse muscle weakness and shrinking after an ACL tear and reconstruction, with patients who have or will have ACL injuries in mind.

More ACL Injury research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Kentucky
NIH-funded
Lab location1 site (Lexington, United States)
Project startAugust 30, 2024
Project endJuly 31, 2029
Funding year2026
Award (this year)$473,121
NIH project number5R01AR083375-03
Project IDNIH-11382049 on NIH RePORTER

Who could benefit from this research

Could help

Ideal participants are individuals with ACL injury undergoing or having undergone reconstruction, who are at risk for quadriceps weakness and atrophy.

Less likely to help

Patients whose ACL injury does not lead to quadriceps weakness or who cannot receive NMES as part of their care may see limited direct benefit.

What this research studies

After an ACL injury and reconstruction, patients often have lasting weakness and muscle loss in the quadriceps. This project explores the body’s signaling pathways that lead to this muscle change and examines how NMES (nerve-stimulating electrical therapy) can influence those signals. The study builds on pilot data showing a molecular signature of quadriceps dysfunction that NMES may modify, aiming to clarify why some people recover better than others. The investigators plan to use mechanistic experiments to connect ACL injury to nerve and muscle changes and to test NMES as a targeted intervention. The ultimate goal is to inform rehabilitation strategies that reduce proximal muscle deficits and improve return-to-activity outcomes.

Why it matters

Potential benefit: If successful, NMES could become a targeted part of rehabilitation to prevent or lessen quadriceps weakness after ACL injury, potentially shortening recovery time and improving function.

How similar studies have gone: Previous work suggests NMES can affect nerve-muscle signaling, but robust mechanistic studies in humans are still emerging.

Where this research is happening

  • University of Kentucky
    Lexington, United States
    Active

Researchers

  • Principal investigator: Fry, Christopher — University of Kentucky
  • Study coordinator: Fry, Christopher

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.